Omvik P, Lund-Johansen P
Medical Department, University of Bergen, School of Medicine, Haukeland Hospital, Bergen, Norway.
Ann Clin Res. 1988;20 Suppl 48:23-30.
Dihydropyridine and verapamil-like calcium channel blockers reduce blood pressure (BP) in essential hypertension (EH) but have different effects on heart rate (HR) at rest. This study compares the HR and hemodynamic responses to exercise of long-term treatment with nifedipine, nisoldipine, verapamil, tiapamil and diltiazem in five groups of patients with mild and moderate EH (diastolic BP ranging 100-120 mmHg). In a total of 76 patients (mean age 43 years) BP was measured intraarterially, cardiac output by dye dilution (Cardiogreen) and HR by electrocardiogram. Acutely HR and cardiac index (CI) rose (9 and 12%) while BP and total peripheral resistance index (TPRI) were reduced (9 and 19%). After one year calcium channel blockade intraarterial pressure at rest sitting fell from 172/105 to 150/91 mmHg (13%) and at 100 W exercise from 205/109 to 188/97 mmHg (10%). HR remained unchanged in the dihydropyridine groups (range +/- 3%) in all situations while it invariably fell (range 3 to 15%) in the groups treated with verapamil-like calcium blockers. The fall in HR was greater during exercise than at rest (mean 10% vs 6%). With these drugs stroke volume (SV) tended to increase (range 1 to 10%) while it remained unchanged in the dihydropyridine groups. Only minor changes were seen in CO. In all groups the TPRI fell, averaging 15% at rest and during exercise. Thus, the verapamil-like calcium blockers induce a negative chronotropic effect that is enhanced during work, but the cardiac pump function is preserved by a compensatory increase in SI. Independent on the cardiac responses both groups of calcium blockers lower BP by peripheral vasodilatation both at rest and during exercise.
二氢吡啶类和维拉帕米样钙通道阻滞剂可降低原发性高血压(EH)患者的血压(BP),但对静息心率(HR)有不同影响。本研究比较了硝苯地平、尼索地平、维拉帕米、替帕米和地尔硫䓬长期治疗对五组轻中度EH患者(舒张压范围为100-120 mmHg)运动时心率和血流动力学的影响。共有76例患者(平均年龄43岁),通过动脉内测量血压,通过染料稀释法(Cardiogreen)测量心输出量,通过心电图测量心率。急性情况下,心率和心脏指数(CI)升高(分别为9%和12%),而血压和总外周阻力指数(TPRI)降低(分别为9%和19%)。一年的钙通道阻滞治疗后,静息坐位时动脉内压从172/105 mmHg降至150/91 mmHg(下降13%),100 W运动时从205/109 mmHg降至188/97 mmHg(下降10%)。在所有情况下,二氢吡啶类药物组的心率保持不变(变化范围为±3%),而维拉帕米样钙阻滞剂治疗组的心率总是下降(变化范围为3%至15%)。运动时心率下降幅度大于静息时(平均分别为10%和6%)。使用这些药物时,每搏输出量(SV)有增加趋势(变化范围为1%至10%),而二氢吡啶类药物组则保持不变。心输出量(CO)仅有轻微变化。所有组的TPRI均下降,静息和运动时平均下降15%。因此,维拉帕米样钙阻滞剂可诱发负性变时作用,在运动时增强,但通过SI的代偿性增加维持心脏泵功能。两组钙通道阻滞剂均通过外周血管舒张在静息和运动时降低血压,与心脏反应无关。